Terumo has completed its previously announced purchase of OrganOx for nearly $1.5bn after meeting all necessary regulatory ...

EndoQuest Robotics is collaborating with NVIDIA to integrate protocols within its endoluminal robotic surgery technology as ...

Boston Scientific has lifted its fiscal year 2025 (FY25) profit outlook to between $3.02 and $3.04 per share amid continued ...

Elucid has launched PlaqueIQ, an AI-based image analysis software that quantifies plaque build-up to evaluate a patient’s ...

Roche has obtained CE mark approval for its fully automated immunoassay, Elecsys Dengue Ag test, intended for diagnosing ...

GE HealthCare has raised its fiscal year 2025 (FY25) profit outlook to between $3.02 and $3.04 per share amid solid demand ...

The FDA has granted breakthrough device designation to Augurex’s SPINEstat 14-3-3eta Autoantibody Multiplex Immunoassay Test.

Edwards Lifesciences has raised its fiscal year (FY25) guidance to between $2.56 to $2.62 per share after achieving better ...

Co-Dx has signed a definitive agreement with Arabian Eagle Manufacturing to create a joint venture (JV) for PCR platform ...

As healthcare systems increasingly turn to personalised approaches, Belgian company Materialise is accelerating efforts to ...

South Korea-based MOPIC has introduced an autostereoscopic 3D display aimed at endoscopic and microscope imaging applications ...

A sales probe from Organon's board has found evidence of wholesaler sales malpractice, resulting in Ali's resignation and a ...